https://www.bloomberg.com/news/articles/2021-04-02/u-k-sees-25-new-blood-clot-cases-linked-to-astrazeneca-vaccine
The U.K. government said there have been 25 new reports of rare types of blood clots linked to AstraZeneca Plc’s Covid-19 vaccine recently, adding to the numbers that have caused European countries to adopt precautionary measures.
U.K. Sees 25 New Blood-Clot Cases Linked to AstraZeneca Vaccine
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- Pound Sterling Price News and Forecast: GBP/USD slips despite strong UK Retail Sales as USD dominance prevails
- US Dollar climbs as trade rumors fuel market speculation
- US President Trump: We will be reasonable on tariffs
- Dow Jones dips as trade uncertainty lingers, consumer sentiment sinks
- USD/CAD holds firm as mixed trade headlines cloud USD outlook
- Research: When Leaders Express Positivity Early On, Employees Perform Better
- 7 AI Tools That Help You Build a One-Person Business — and Make Money While You Sleep
- Microsoft Created an Ad Using AI and No One Picked Up On It: ‘Saved 90% of the Time and Cost’
- This Quiet Shift Is Helping Founders Build Fierce Customer Loyalty
- Want to Boost Your Profits by Up to 95%? Focus on This Underrated Metric.
More from UncategorizedMore posts in Uncategorized »
- Pound Sterling Price News and Forecast: GBP/USD slips despite strong UK Retail Sales as USD dominance prevails
- US Dollar climbs as trade rumors fuel market speculation
- US President Trump: We will be reasonable on tariffs
- Dow Jones dips as trade uncertainty lingers, consumer sentiment sinks
- USD/CAD holds firm as mixed trade headlines cloud USD outlook
- Research: When Leaders Express Positivity Early On, Employees Perform Better
- 7 AI Tools That Help You Build a One-Person Business — and Make Money While You Sleep
- Microsoft Created an Ad Using AI and No One Picked Up On It: ‘Saved 90% of the Time and Cost’
- This Quiet Shift Is Helping Founders Build Fierce Customer Loyalty
- Want to Boost Your Profits by Up to 95%? Focus on This Underrated Metric.